COPD and multimorbidity: recognising and addressing a syndemic occurrence

LM Fabbri, BR Celli, A Agustí, GJ Criner… - The Lancet …, 2023 - thelancet.com
Most patients with chronic obstructive pulmonary disease (COPD) have at least one
additional, clinically relevant chronic disease. Those with the most severe airflow obstruction …

Current progress of COPD Early detection: key points and novel strategies

CH Lin, SL Cheng, CZ Chen, CH Chen… - … Journal of Chronic …, 2023 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide, with approximately 70% to 80% of adults with COPD being undiagnosed …

Comorbidities and mortality among patients with chronic obstructive pulmonary disease

N Skajaa, K Laugesen… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
Introduction Comorbidities are common in patients with chronic obstructive pulmonary
disease (COPD). Estimates of prevalence, incidence and prognostic impact of comorbidities …

Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort

Z Wang, Y Li, J Lin, J Huang… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
Background Chronic obstructive pulmonary disease (COPD) has been considered a
disease of the elderly, but it could also occur in young people aged 20–50 years. However …

Diffusing capacity as an independent predictor of acute exacerbations in chronic obstructive pulmonary disease

H Park, HJ Lee, JK Lee, TY Park, KN Jin, EY Heo… - Scientific Reports, 2024 - nature.com
A weak correlation between diffusing capacity of the lung for carbon monoxide (DLCO) and
emphysema has been reported. This study investigated whether impaired DLCO in chronic …

Sex differences in comorbidities and mortality risk among patients with chronic obstructive pulmonary disease: a study based on NHANES data

N Li, X Li, M Liu, Y Wang, J Wang - BMC Pulmonary Medicine, 2023 - Springer
Background Patients with chronic obstructive pulmonary disease (COPD) commonly have
coexisting comorbidities that contribute to higher exacerbation frequency, poorer health …

Association between urinary phthalate metabolites and chronic obstructive pulmonary disease incidence in US adults: Results from NHANES 2007–2018

J Shen, Y Wang, S Zhou, M Tang, M Li, R Han… - … Science and Pollution …, 2023 - Springer
Despite associations between urinary phthalates and respiratory symptoms and disorders
have been investigated, knowledge about their impact on COPD incidence remains limited …

The impact of comorbidities on prolonged mechanical ventilation in patients with chronic obstructive pulmonary disease

KM Liao, HY Lu, CY Chen, LT Kuo, BR Tang - BMC Pulmonary Medicine, 2024 - Springer
Background In patients with chronic obstructive pulmonary disease (COPD) and acute
respiratory failure, approximately 10% of them are considered to be at high risk for …

Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients

K Waeijen-Smit, M Crutsen, S Keene… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Exacerbations of COPD (ECOPD) have a major impact on patients and
healthcare systems across the world. Precise estimates of the global burden of ECOPD on …

Introducing the Remote Patient Monitoring Usability Model to Overcome Challenges

S Baumann, RT Stone, E Abdelall - Sensors, 2024 - mdpi.com
Telehealth and remote patient monitoring (RPM), in particular, have been through a massive
surge of adoption since 2020. This initiative has proven potential for the patient and the …